Skip to main content
2026 AABB Annual Meeting Main banner

Education Session

AABB/THOR Debate on the Optimal Product for Fibrinogen Replacement

AM26-MO-21-L - AABB/THOR - Debate on the Optimal Product for Fibrinogen Replacement

Monday, October 19, 2026
2:00 PM - 3:00 PM EST
Room: GWCC B5 Thomas Murphy 2-3

    Program Chair(s)

  • MC

    Melissa Cushing, MD (she/her/hers)

    Director of the Clinical Laboratories, Transfusion Medicine and Cellular Therapy
    Weill Cornell Medicine
    New York, New York

    • Speaker(s)

  • MC

    Melissa Cushing, MD (she/her/hers)

    Director of the Clinical Laboratories, Transfusion Medicine and Cellular Therapy
    Weill Cornell Medicine
    New York, New York

  • Jennifer Andrews, MD, MSc

    Professor of Pathology, Microbiology and Immunology & Pediatrics
    Vanderbilt University Medical Center
    Nashville, Tennessee

  • AZ

    Alyssa Ziman, MD

    Section Chief, Transfusion Medicine; CLIA Medical Director, Clinical Laboratories, Ronald Reagan UCLA Medical Center
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA
    Los Angeles, California